Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 20Gastrointestinal 18Head & Neck 14CNS 14Genitourinary 12Breast 10Sarcoma 9Other hematologic neoplasm 8Lymphoid 8Dermatologic 6Tumor-Agnostic 3Other solid neoplasm 3Myeloid 3Gynecologic 3Other 2Endocrine 1Classical hematology 1

Conditions

Lymphoma, Follicular 1Anemia, Aplastic 1

Interventions

Cyclophosphamide 17fludarabine phosphate 14Whole-Body Irradiation 11Mycophenolic Acid 9Epoetin Alfa 9Cyclosporine 9Busulfan 9fludarabine 8Cord Blood Stem Cell Transplantation 8Antilymphocyte Serum 8Filgrastim 6Tacrolimus 5Radiotherapy 5Peripheral Blood Stem Cell Transplantation 5Methotrexate 5Darbepoetin alfa 5Dalteparin 5Cytarabine 5eltrombopag 4Tinzaparin 4Thiotepa 4Platelet Transfusion 4Melphalan 4Etoposide 4Arsenic Trioxide 4thymoglobulin 3epoetin beta 3Vorinostat 3Transplantation 3Methylprednisolone 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Radiation × Classical hematology × Clear all
NCT00578903 2016-04-22

Allogeneic Stem Cell Transplant for Patients With Severe Aplastic Anemia

Baylor College of Medicine

Phase 2 Terminated
22 enrolled 11 charts
Classical hematologyLymphoid

Anemia, Aplastic, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡